Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
Completed
Stanford University
Phase 2
2006-01-01
This clinical trial studies the use of sodium fluorine-18 (18F-NaF) plus fluorine-18 (18F)
fluorodeoxyglucose (FDG) positron emission tomography (PET)/ whole body magnetic resonance
imaging (WBMRI) to detect skeletal metastases in patients with stage III-IV breast cancer or
stage II-IV prostate cancer.
Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
Completed
Lantheus Medical Imaging
2009-10-01
Phase 4, open-label, two-year, prospective, multi-center, follow-up study conducted at up 15
sites in USA. Approximately 1,000 patients with moderate-to-severe CKD will be enrolled and
followed for up to 24 months.
Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants
Completed
Lantheus Medical Imaging
N/A
2011-08-01
The purpose of this study is to assess the image quality of Ablavar-enhanced MR angiography
of the central veins of the chest, and to determine whether dose reduction can be performed
while maintaining image quality. This will be a prospective randomized study, in which
healthy volunteers will be recruited to undergo a central veins magnetic resonance angiogram
(MRA). They will receive either the FDA-approved dose or a lower dose of Ablavar.
Quantitative and qualitative analysis will be performed on the images.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.